The role of 17-beta estradiol in ischemic preconditioning protection of the heart

Experimental and Clinical Cardiology

Volumn 17, Issue 3, 2012, Pages 95-100

  Babiker, Fawzi A ^a   Hoteit, Lamia J ^a   Joseph, Shaji ^a   Mustafa, Abu Salim ^a   Juggi, Jasbir S ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Estrogen; Ischemia; Preconditioning; Reperfusion; Tumour necrosis factor alpha

Indexed keywords

ESTRADIOL; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEART HEMODYNAMICS; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; ISOLATED HEART; LONG TERM CARE; MALE; NONHUMAN; OVARIECTOMY; RAT; REPERFUSION INJURY;

EID: 84867468041     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36. (Pubitemid 17174962)
2. Gysembergh A, Margonari H, Loufoua J, et al. Stretch-induced protection shares a common mechanism with ischemic preconditioning in rabbit heart. Am J Physiol 1998;274:H955-64.
3. Huang CH, Wang JS, Chiang SC, Wang YY, Lai ST, Weng ZC. Brief pressure overload of the left ventricle preconditions rabbit myocardium against infarction. Ann Thorac Surg 2004;78:628-33. (Pubitemid 38980787)
4. Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Lonovics J, Koltai M. Ventricular overdrive pacing-induced anti-ischemic effect: A conscious rabbit model of preconditioning. Am J Physiol 1994;266:H2033-41. (Pubitemid 24172145)
5. Vanagt WY, Cornelussen RN, Poulina QP, et al. Pacing-induced dys-synchrony preconditions rabbit myocardium against ischemia/reperfusion injury. Circulation 2006;114:I264-9. (Pubitemid 44297161)
6. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
7. Palacios S. The future of the new selective estrogen receptor modulators. Menopause Int 2007;13:27-34. (Pubitemid 46692067)
8. Palacios S. Selective estrogen receptor modulators: The future in menopausal treatment. Minerva Ginecol 2011;63:275-86.
9. Shelly W, Draper MW, Krishnan V, Wong M, Jaffe RB. Selective estrogen receptor modulators: An update on recent clinical findings. Obstet Gynecol Surv 2008;63:163-81. (Pubitemid 351612435)
10. Babiker FA, Lips DJ, Delvaux E, et al. Oestrogen modulates cardiac ischaemic remodelling through oestrogen receptor-specific mechanisms. Acta Physiol (Oxf) 2007;189:23-31. (Pubitemid 46092427)
11. Zhang Y, Zhong N, Zhou ZN. Estradiol potentiates antiarrhythmic and antioxidative effects of intermittent hypoxic rat heart. Acta Pharmacol Sin 2000;21:609-12. (Pubitemid 30482930)
12. Das B, Sarkar C. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart. J Cardiovasc Pharmacol 2006;47:277-86. (Pubitemid 44389140)
13. McNulty PH, Jagasia D, Whiting JM, Caulin-Glaser T. Effect of 6-wk estrogen withdrawal or replacement on myocardial ischemic tolerance in rats. Am J Physiol Heart Circ Physiol 2000;278:H1030-4. (Pubitemid 30235476)
14. Humphreys RA, Kane KA, Parratt JR. The influence of maturation and gender on the anti-arrhythmic effect of ischaemic preconditioning in rats. Basic Res Cardiol 1999;94:1-8. (Pubitemid 29103606)
15. Song X, Li G, Vaage J, Valen G. Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischaemia-reperfusion injury in mice. Acta Physiol Scand 2003;177:459-66. (Pubitemid 36411583)
16. Sovershaev MA, Egorina EM, Andreasen TV, Jonassen AK, Ytrehus K. Preconditioning by 17beta-estradiol in isolated rat heart depends on PI3-K/PKB pathway, PKC, and ROS. Am J Physiol Heart Circ Physiol 2006;291:H1554-62. (Pubitemid 44497658)
17. Peng WJ, Yu J, Deng S, Jiang JL, Deng HW, Li YJ. Effect of estrogen replacement treatment on ischemic preconditioning in isolated rat hearts. Can J Physiol Pharmacol 2004;82:339-44. (Pubitemid 39093700)
18. Xu Y, Arenas IA, Armstrong SJ, Plahta WC, Xu H, Davidge ST. Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha. Cardiovasc Res 2006;69:836-44. (Pubitemid 43227982)
19. Shinmura K, Nagai M, Tamaki K, Bolli R. Loss of ischaemic preconditioning in ovariectomized rat hearts: Possible involvement of impaired protein kinase C epsilon phosphorylation. Cardiovasc Res 2008;79:387-94.
20. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res 1997;81:187-95. (Pubitemid 27342485)
21. Bhalla DK, Reinhart PG, Bai C, Gupta SK. Amelioration of ozone-induced lung injury by anti-tumor necrosis factor-alpha. Toxicol Sci 2002;69:400-8. (Pubitemid 35244214)
22. Meldrum DR, Dinarello CA, Shames BD, et al. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning. Circulation 1998;98:II214-8; discussion II218-9.
23. Perepu RS, Garcia C, Dostal D, Sethi R. Enhanced death signaling in ozone-exposed ischemic-reperfused hearts. Mol Cell Biochem 2010;336:55-64.
24. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-9.
25. Lecour S, Smith RM, Woodward B, Opie LH, Rochette L, Sack MN. Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol 2002;34:509-18.
26. Ghadhanfar EA, Juggi JS. Effect of preconditioning temperature on cardioprotection during global ischemia-reperfusion in the rat heart. Exp Clin Cardiol 2007;12:11-6. (Pubitemid 46566810)
27. Sullivan TR Jr, Karas RH, Aronovitz M, et al. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995;96:2482-8.
28. Juggi JS, Hoteit LJ, Babiker FA, Joseph S, Mustafa AS. Protective role of normothermic, hyperthermic and estrogen preconditioning and pretreatment on tumour necrosis factor-alpha-induced damage. Exp Clin Cardiol 2011;16:e5-10.
29. Zhang Y, Stewart KG, Davidge ST. Estrogen replacement reduces age-associated remodeling in rat mesenteric arteries. Hypertension 2000;36:970-4.
30. Kin H, Wang NP, Halkos ME, Kerendi F, Guyton RA, Zhao ZQ. Neutrophil depletion reduces myocardial apoptosis and attenuates NFkappaB activation/TNFalpha release after ischemia and reperfusion. J Surg Res 2006;135:170-8. (Pubitemid 44215908)
31. Yang J, Jiang H, Ding JW, Chen LH, Li S, Zhang XD. Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway. Mol Cell Biochem 2009;330:39-46.
32. Edmunds NJ, Lal H, Woodward B. Effects of tumour necrosis factor-alpha on left ventricular function in the rat isolated perfused heart: Possible mechanisms for a decline in cardiac function. Br J Pharmacol 1999;126:189-96. (Pubitemid 29041757)
33. Oral H, Dorn GW, 2nd, Mann DL. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. J Biol Chem 1997;272:4836-42. (Pubitemid 27090030)
34. Loke KE, Woodman OL. Preconditioning improves myocardial function and reflow, but not vasodilator reactivity, after ischaemia and reperfusion in anaesthetized dogs. Clin Exp Pharmacol Physiol 1998;25:552-8. (Pubitemid 28321620)
35. Smith RM, Suleman N, McCarthy J, Sack MN. Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene. Cardiovasc Res 2002;55:553-60. (Pubitemid 34874950)
36. Kimura H, Shintani-Ishida K, Nakajima M, Liu S, Matsumoto K, Yoshida K. Ischemic preconditioning or p38 MAP kinase inhibition attenuates myocardial TNF alpha production and mitochondria damage in brief myocardial ischemia. Life Sci 2006;78:1901-10.
37. Hiasa G, Hamada M, Ikeda S, Hiwada K. Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor-kappaB activation and gene expression of inflammatory cytokines in the ischemia-reperfused rat heart. Jpn Circ J 2001;65:984-90.
38. Anderson SE, Kirkland DM, Beyschau A, Cala PM. Acute effects of 17beta-estradiol on myocardial pH, Na+, and Ca2+ and ischemia-reperfusion injury. Am J Physiol Cell Physiol 2005;288:C57-64.
39. Morkuniene R, Arandarcikaite O, Ivanoviene L, Borutaite V. Estradiol-induced protection against ischemia-induced heart mitochondrial damage and caspase activation is mediated by protein kinase G. Biochim Biophys Acta 2010;1797:1012-7.
40. Booth EA, Marchesi M, Kilbourne EJ, Lucchesi BR. 17Beta-estradiol as a receptor-mediated cardioprotective agent. J Pharmacol Exp Ther 2003;307:395-401.
41. Squadrito F, Altavilla D, Squadrito G, et al. The involvement of tumour necrosis factor-alpha in the protective effects of 17 beta oestradiol in splanchnic ischaemia-reperfusion injury. Br J Pharmacol 1997;121:1782-8. (Pubitemid 27343411)
42. Beyer ME, Yu G, Hanke H, Hoffmeister HM. Acute gender-specific hemodynamic and inotropic effects of 17beta-estradiol on rats. Hypertension 2001;38:1003-10. (Pubitemid 34252797)
43. Mugge A, Riedel M, Barton M, Kuhn M, Lichtlen PR. Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro. Cardiovasc Res 1993;27:1939-42. (Pubitemid 23357336)
44. Liao SL, Chen WY, Chen CJ. Estrogen attenuates tumor necrosis factor-alpha expression to provide ischemic neuroprotection in female rats. Neurosci Lett 2002;330:159-62.
45. Jiang CW, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Br J Pharmacol 1991;104:1033-7.
46. Wellman GC, Bonev AD, Nelson MT, Brayden JE. Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca(2+)-dependent K+ channels. Circ Res 1996;79:1024-30. (Pubitemid 26359243)
47. Shinbo A, Iijima T. Potentiation by nitric oxide of the ATP-sensitive K+ current induced by K+ channel openers in guinea-pig ventricular cells. Br J Pharmacol 1997;120:1568-74. (Pubitemid 27192450)
48. Gross GJ, Fryer RM. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ Res 1999;84:973-9. (Pubitemid 29227676)
49. Yang XM, Philipp S, Downey JM, Cohen MV. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 2005;100:57-63. (Pubitemid 40069107)
50. Honma Y, Tani M, Takayama M, Yamamura K, Hasegawa H. Aging abolishes the cardioprotective effect of combination heat shock and hypoxic preconditioning in reperfused rat hearts. Basic Res Cardiol 2002;97:489-95. (Pubitemid 35373477)
51. Honma Y, Tani M, Yamamura K, Takayama M, Hasegawa H. Preconditioning with heat shock further improved functional recovery in young adult but not in middle-aged rat hearts. Exp Gerontol 2003;38:299-306. (Pubitemid 36170325)
52. Featherstone RL, Chambers DJ. Long-term hypothermic lung preservation: Does adenosine A1 receptor antagonism have a role in ischemic preconditioning protection? Interact Cardiovasc Thorac Surg 2004;3:182-87. (Pubitemid 38481829)
53. Skyschally A, Gres P, Hoffmann S, et al. Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: Progressive contractile dysfunction versus delayed protection against infarction. Circ Res 2007;100:140-6. (Pubitemid 46066782)